Cite
DIAGNOSIS OF INSULIN RESISTANCE IN PATIENTS AT HIGH CARDIOVASCULAR RISK: FOCUS ON PEPTIDE HORMONE GHRELIN
MLA
E. V. Belik, et al. “Diagnosis of Insulin Resistance in Patients at High Cardiovascular Risk: Focus on Peptide Hormone Ghrelin.” Атеросклероз, vol. 15, no. 3, Sept. 2019, pp. 42–49. EBSCOhost, https://doi.org/10.15372/ATER20190303.
APA
E. V. Belik, O. V. Gruzdeva, Yu. A. Dyleva, T. R. Dolinchik, A. A. Kuz’mina, & E. E. Bychkova. (2019). Diagnosis of Insulin Resistance in Patients at High Cardiovascular Risk: Focus on Peptide Hormone Ghrelin. Атеросклероз, 15(3), 42–49. https://doi.org/10.15372/ATER20190303
Chicago
E. V. Belik, O. V. Gruzdeva, Yu. A. Dyleva, T. R. Dolinchik, A. A. Kuz’mina, and E. E. Bychkova. 2019. “Diagnosis of Insulin Resistance in Patients at High Cardiovascular Risk: Focus on Peptide Hormone Ghrelin.” Атеросклероз 15 (3): 42–49. doi:10.15372/ATER20190303.